statistiche ricercatore

Continente	#
NA - Nord America	1.481
AS - Asia	381
EU - Europa	280
SA - Sud America	53
Continente sconosciuto - Info sul continente non disponibili	43
AF - Africa	10
OC - Oceania	1
Totale	2.249

Nazione	#
US - Stati Uniti d'America	1.453
SG - Singapore	136
IT - Italia	88
KR - Corea	56
CN - Cina	54
RU - Federazione Russa	40
BR - Brasile	39
VN - Vietnam	34
HK - Hong Kong	29
SE - Svezia	29
BD - Bangladesh	28
DE - Germania	28
IE - Irlanda	18
FR - Francia	15
FI - Finlandia	14
UA - Ucraina	13
CA - Canada	12
JP - Giappone	12
MX - Messico	10
GB - Regno Unito	8
AR - Argentina	7
BE - Belgio	7
IN - India	7
PL - Polonia	7
NL - Olanda	6
EC - Ecuador	4
ID - Indonesia	4
IQ - Iraq	3
SA - Arabia Saudita	3
CR - Costa Rica	2
CZ - Repubblica Ceca	2
DZ - Algeria	2
ES - Italia	2
IL - Israele	2
IR - Iran	2
KE - Kenya	2
KG - Kirghizistan	2
TH - Thailandia	2
AL - Albania	1
AT - Austria	1
AU - Australia	1
BG - Bulgaria	1
CG - Congo	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
EG - Egitto	1
GH - Ghana	1
GT - Guatemala	1
JM - Giamaica	1
JO - Giordania	1
KZ - Kazakistan	1
ML - Mali	1
MM - Myanmar	1
MY - Malesia	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
PY - Paraguay	1
SC - Seychelles	1
TR - Turchia	1
TT - Trinidad e Tobago	1
ZA - Sudafrica	1
Totale	2.207

Nome	#
C-peptide: A predictor of cardiovascular mortality in subjects with established atherosclerotic disease	561
2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease	412
Brachial flow-mediated dilation predicts glycemia worsening in normoglycemic young subjects	379
IL-6 Levels Influence 3-Month All-Cause Mortality in Frail Hospitalized Older Patients	229
Attending an integrated nephrology and diabetology outpatient service can improve diabetic kidney disease treatment: a single-center experience	169
Miglioramento della funzione predittiva del Framingham Score mediante l’utilizzo di substrati di ADAM 17	153
Risk Factors for Ulcer Recurrence in Diabetic Patients Managed by an Integrated Foot Care Protocol	112
Prevalence of Diabetes Mellitus and Clinical Differences in Patients with Severe Osteoporosis and Fragility Fractures	104
Diabetic Polyneuropathy and Physical Activity in Type 1 Diabetes Mellitus: A Cross-Sectional Study	100
Metabolic and renal effects of combined SGLT-2 inhibitors and GLP1-R agonists therapy in type 2 diabetes: a real-world analysis across DKD and non-DKD patients	30
Totale	2.249

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	57	0	0	0	4	1	10	2	4	10	5	5	16
2022/2023	103	9	11	9	14	10	18	18	4	2	0	6	2
2023/2024	75	10	2	5	1	5	22	6	12	0	0	0	12
2024/2025	230	9	34	15	10	5	19	23	16	31	19	24	25
2025/2026	579	36	31	57	70	48	24	76	52	59	42	42	42
2026/2027	278	45	31	85	117	0	0	0	0	0	0	0	0
Totale													2.249